Gaudium IVF and Women Health Key Ratios
NSE: GAUDIUMIVF | BSE: 544709
₹114.42
As on 15-Sep-2026IST
Market cap
₹836 Cr
Revenue (TTM)
₹71 Cr
P/E Ratio
34.2
P/B Ratio
5.4
Div. Yield
0 %
Key Ratios and Highlights
| Growth Score (%) | Quarterly | Annual (TTM) | |||
|---|---|---|---|---|---|
| Particulars | QoQ | YoY | 1-Year | 3-Years | 5-Years |
| Revenue | -36.16 | 9.13 | 47.68 | 24.65 | -- |
| EBIT | -85.24 | -62.55 | 55.27 | 28.81 | -- |
| Net Profit | -78.75 | -42.26 | 85.40 | 29.40 | -- |
| EPS | -78.75 | -51.27 | 85.39 | 29.40 | -- |
| Book Value | -- | -- | 71.55 | 70.78 | -- |
| Key Ratios (%) | Average | Annual (TTM) | |||
|---|---|---|---|---|---|
| Particulars | 3-Years | 5-Years | Mar-25 | Mar-24 | Mar-23 |
| EBIT-Margin
| 38.82 | -- | 37.94 | 36.08 | 42.45 |
| Net Margin
| 26.31 | -- | 26.96 | 21.43 | 30.56 |
| Return on equity
| 59.39 | -- | 52.20 | 41.50 | 84.47 |
| Return on Capital
| 58.51 | -- | 50.15 | 46.65 | 78.74 |
| Return on Assets
| 33.63 | -- | 27.42 | 23.55 | 49.92 |
| Debt to Equity (x)
| -- | -- | 0.41 | 0.58 | 0.43 |
Profitability
ROCE
50.15
Higher than Peers by 31.07
Earning before interest and taxes / (Average net worth + Average total Debt) * 100
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Gaudium IVF and Women Health
|
50.15
|
46.65
|
78.74
|
82.39
|
--
|
|
Peer Median
|
19.08
|
17.78
|
15.96
|
4.83
|
--
|
ROE
52.20
Higher than Peers by 37.94
Profit after tax / Average Net worth * 100
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Gaudium IVF and Women Health
|
52.20
|
41.50
|
84.47
|
94.99
|
--
|
|
Peer Median
|
14.26
|
17.43
|
16.41
|
2.15
|
--
|
ROA
27.42
Higher than Peers by 17.85
Profit after tax / Average Total assets * 100
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Gaudium IVF and Women Health
|
27.42
|
23.55
|
49.92
|
50.27
|
--
|
|
Peer Median
|
9.57
|
8.31
|
7.08
|
0.81
|
--
|
EBIT Margin
37.94
Higher than Peers by 20.07
Operating profit (EBIT) / Net Sales * 100
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Gaudium IVF and Women Health
|
37.94
|
36.08
|
42.45
|
34.38
|
--
|
|
Peer Median
|
17.87
|
18.12
|
12.75
|
11.61
|
--
|
Net Margin
26.96
Higher than Peers by 17.13
Net profit / Total Income (Net sales plus other income) * 100
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Gaudium IVF and Women Health
|
26.96
|
21.43
|
30.56
|
24.17
|
--
|
|
Peer Median
|
9.83
|
9.95
|
9.16
|
0.83
|
--
|
Cash Profit Margin
29.94
--
(Net profit + Depreciation) / Gross Sales * 100
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Gaudium IVF and Women Health
|
29.94
|
26.05
|
33.82
|
26.83
|
--
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Revenue Growth
47.68
Higher than Peers by 31.43
Year on year growth in net sales
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Gaudium IVF and Women Health
|
47.68
|
8.26
|
21.13
|
--
|
--
|
|
Peer Median
|
16.25
|
16.01
|
16.23
|
29.29
|
--
|
EBIT Growth
55.27
Higher than Peers by 35.96
Year on year growth in operating profit (EBIT)
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Gaudium IVF and Women Health
|
55.27
|
-7.97
|
49.56
|
--
|
--
|
|
Peer Median
|
19.31
|
20.43
|
18.62
|
411.57
|
--
|
Net Profit Growth
85.40
Higher than Peers by 67.98
Year on year growth in profit after tax
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Gaudium IVF and Women Health
|
85.40
|
-23.72
|
53.21
|
--
|
--
|
|
Peer Median
|
17.42
|
25.57
|
23.10
|
288.14
|
--
|
EPS Growth
85.39
Higher than Peers by 69.14
Year on year growth in earnings per share
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Gaudium IVF and Women Health
|
85.39
|
-23.72
|
53.21
|
--
|
--
|
|
Peer Median
|
16.25
|
--
|
50.00
|
274.52
|
--
|
Book Value Growth
71.56
--
Year on year growth in book value per share
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Gaudium IVF and Women Health
|
71.56
|
18.73
|
144.56
|
--
|
--
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Solvency
Debt to Equity
0.41
Higher than Peers by 0.10
Total debt / Net worth
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Gaudium IVF and Women Health
|
0.41
|
0.58
|
0.43
|
0.64
|
--
|
|
Peer Median
|
0.31
|
0.39
|
0.37
|
0.49
|
--
|
Short term debt to equity ratio
0.37
--
(Short term borrowings / Net worth)
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Gaudium IVF and Women Health
|
0.37
|
0.51
|
0.34
|
0.40
|
--
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Current Ratio
1.42
Higher than Peers by 0.05
Current Assets / Current Liabilities and Provisions
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Gaudium IVF and Women Health
|
1.42
|
1.50
|
1.92
|
2.29
|
--
|
|
Peer Median
|
1.37
|
1.58
|
1.32
|
1.29
|
--
|
Quick Ratio
1.23
Lower than Peers by 0.83
(Current Assets - Inventory) / Current Liabilities and Provisions
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Gaudium IVF and Women Health
|
1.23
|
1.39
|
1.76
|
2.23
|
--
|
|
Peer Median
|
2.06
|
1.03
|
1.32
|
1.22
|
--
|
Interest Coverage
16.46
Higher than Peers by 8.91
Earning before interest and taxes (EBIT) / Interest Expenses
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Gaudium IVF and Women Health
|
16.46
|
19.23
|
38.53
|
22.44
|
--
|
|
Peer Median
|
7.55
|
5.83
|
5.17
|
1.55
|
--
|
Operating Efficiency
Debtors to sales
46.47
Higher than Peers by 36.52
Debtors outstanding / Net Sales * 100
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Gaudium IVF and Women Health
|
46.47
|
28.38
|
2.05
|
17.78
|
--
|
|
Peer Median
|
9.95
|
8.40
|
10.55
|
11.20
|
--
|
Asset Turnover
1.01
Higher than Peers by 0.30
Sales / Average Total Assets
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Gaudium IVF and Women Health
|
1.01
|
1.09
|
1.63
|
2.08
|
--
|
|
Peer Median
|
0.72
|
0.80
|
0.85
|
0.72
|
--
|
Receivable days
119.89
--
Average Debtors / Sales * 365
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Gaudium IVF and Women Health
|
119.89
|
55.26
|
30.54
|
64.91
|
--
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Inventory Days
24.08
--
Average Inventory / Sales * 365
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Gaudium IVF and Women Health
|
24.08
|
13.73
|
7.57
|
3.35
|
--
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Payable days
178.13
--
Average Creditors / Cost of goods sold * 365
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Gaudium IVF and Women Health
|
178.13
|
72.31
|
87.50
|
114.13
|
--
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Cash Conversion Cycle
-34.17
--
Receivable Days + Inventory Days - Payable Days
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Gaudium IVF and Women Health
|
-34.17
|
-3.32
|
-49.39
|
-45.87
|
--
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Valuation
Price / Earnings
--
--
Current share price divided by earning per share in the last twelve months
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Gaudium IVF and Women Health
|
--
|
--
|
--
|
--
|
--
|
|
Peer Median
|
52.13
|
48.04
|
41.51
|
48.25
|
--
|
Price / Book Value
--
--
Current share price divided by book value per share in the latest financial year
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Gaudium IVF and Women Health
|
--
|
--
|
--
|
--
|
--
|
|
Peer Median
|
6.84
|
6.39
|
3.37
|
3.56
|
--
|
EV/EBITDA
1.46
Lower than Peers by 43.75
Enterprise Value (Current Market Capitalisation + Total Debt - Cash & Equivalents) / Earnings before interest, taxes, depreciation and taxes (EBITDA)
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Gaudium IVF and Women Health
|
1.46
|
0.25
|
-0.21
|
0.40
|
--
|
|
Peer Median
|
45.21
|
41.01
|
32.71
|
84.51
|
--
|
Market Cap
--
--
Current Share price multiplied by latest total number of shares outstanding
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Gaudium IVF and Women Health
|
--
|
--
|
--
|
--
|
--
|
|
Peer Median
|
10,071
|
5,273
|
7,513
|
6,156
|
--
|